Commercial IPStandard Monitoring

UPC_CFI_1357/2025

Live Docket

European Patent Litigation Tracking · Brussels Local Division

Executive Teardown ↓Request Custom Matter Memo

Judicial Venue

Brussels Local Division

Action Type

procedural

Patent in Suit

EP 3 883 351

Strategic Executive Teardown

For Lead Counsel & Practice Groups

Substantive Docket Action in Brussels Local Division

Key Holding: The court rendered an order addressing procedural posture and merits under applicable procedural rules.

🎯 Litigator Takeaway & Practice Pointer

Litigators with parallel exposure across Europe should monitor this docket closely to evaluate evidentiary cross-admissibility and claim construction harmony.

⏱️ Procedural Horizon & Next Milestones

Substantive responses and evidence bundles are scheduled for submission under the expedited statutory timeline.

Cross-Border Multi-Front Litigation Matrix

Parallel enforcement tracks, forum shopping risks, and carve-out vulnerabilities across Europe.

Conflict Risk: Moderate

Brussels Local Division

active

Direct pan-European enforcement (17 states)

UK High Court (London)

potential

Parallel UK market litigation (post-Brexit)

EPO Opposition Division (Munich)

potential

Dual-track administrative opposition

Patent Asset & Commercial Exposure

Technology Field

Biopharmaceutical Formulation / Biologics

Unitary Status

Unitary Patent (UP)

SEP / FRAND Classification

Standard Patent

Commercial Stakes

PCSK9 Monoclonal Antibody (Alirocumab / Evolocumab - €1.8B Global Sales)

Parties & Representing Counsel of Record

Claimant / Patentee

1. GC AESTHETICS PARENTCO LIMITED 2. NAGOR LIMITED 3. GC AESTHETICS MANAGEMENT LIMITED 4. GC AESTHETICS (DISTRIBUTION) LIMITED 5. GC AESTHETICS (France) SAS 6. EUROSILICONE SAS 7. GC AESTHETICS ITALY S.R.L. 8. GC AESTHETICS GmbH 9. GC AESTHETICS SPAIN

Representative Law Firm: Counsel on Record

Defendant / Opponent

GC Aesthetics ParentCo Limited Nagor Limited GC Aesthetics Management Limited GC Aesthetics (Distribution) Limited GC Aesthetics (France) SAS EuroSilicone SAS GC Aesthetics Italy S.R.L. GC Aesthetics GmbH GC Aesthetics Spain

Representative Law Firm: Counsel on Record

Venue & Judicial Speed Benchmarks

Speed to Preliminary Order

34 days

Median from filing

Injunction Grant Propensity

72%

Division historical average

Language of Proceedings

English (70%) / German (30%)

Bench Procedural Tendency

Technically rigorous, high urgency threshold, pro-expedited timeline

Published Orders & Court Decisions

5 published order(s)

UPC_DOC_02dd051d-213d-4722-b5de-d27ddb69ee41

Issued 2026-08-14

procedural